<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03583047</url>
  </required_header>
  <id_info>
    <org_study_id>CONS0008-2014-1</org_study_id>
    <nct_id>NCT03583047</nct_id>
  </id_info>
  <brief_title>Intracoronary Features in the Prognosis of Endothelial Dysfunction and MACES in Population With Acute Coronary Syndrome</brief_title>
  <acronym>iphoneSPACE</acronym>
  <official_title>Intracoronary Profile of Inflammation, Oxidative Stress and Endothelial Progenitor Cells (EPCs) in the Prognosis of Endothelial Dysfunction, Stent Re-stenosis and Cardiovascular Events in Population With Acute Coronary Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary Artery Disease (CAD) is common in Mexico, while morbidity and mortality is high.
      Drug therapy can relieve angina pain and stabilize plaque, but it is not able to re-flow a
      coronary artery. Balloon angioplasty and/or stent placement, re-establishes coronary blood
      flow; however, the risk of re-stenosis and/or development of new coronary events remains
      latent. Endothelial damage, reflected by the degree of endothelial dysfunction, inflammation
      and oxidative stress, promotes atherogenesis, which plays a central role in the
      pathophysiology of CAD. These mechanisms have been studied in animal models; however, it is
      widely unknown whether it influences the coronary circulation in humans. Therefore the
      present study explores the impact of an intracoronary profile of biomarkers of endothelial
      dysfunction, inflammation and oxidative stress on the prognosis of coronary remodeling and
      new adverse cardiovascular events in patients with chronic stable coronary syndrome
      undergoing angioplasty and stent placement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: Observational, longitudinal, analytic and prospective cohort study.

      .With the Ethics and institutional investigation Committee acceptance, patients with stable
      coronary plaque or post-infarct angina with indicated coronary angiography and stent
      placement, from the Hemodynamic Unit from the National Medical Center &quot;20 de Noviembre&quot; of
      the Institute of Security and Social Services of State Workers (ISSSTE) are invited to
      participate. Patients who agree to participate in the study sign the informed consent. The
      independent variables will be the coronary profile components (oxidative stress, inflammation
      and endothelial disfunction biomarkers) and the consequence variables (dependent) will be the
      coronary and/or stent remodeling during the post-angioplasty with stent placement monitoring,
      Major Adverse Cardiovascular Events (MACE) during the post-angioplasty with stent placement
      monitoring period.

      Clinical data:

      to homogenize the study population respect to potentially confusing variables, information
      about sex, age, body mass index, vital signs. lipid profile. co-morbility presence like
      systemic arterial hypertension, diabetes mellitus, metabolic syndrome, drugs and troponin
      determination for stratify the acute coronaropathy.

      Coronary Catheterization and sampling. The coronary catheterization (angioplasty with stent
      placement) is made under medical indication.

      -Coronary catheterism: Is made in the hemodynamic laboratory. Asepsis, antisepsis and local
      anesthesia are performed in the intravascular approach area.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date type="Actual">January 15, 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development of any Major Adverse Cardiovascular Event (MACE)</measure>
    <time_frame>3 months</time_frame>
    <description>Development of any MACE (a combination of major cardiovascular events, including death, heart failure, post-infarction angina, or new myocardial infarction) during a 3 months follow-up after angioplasty and stent placement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development of any Major Adverse Cardiovascular Event (MACE)</measure>
    <time_frame>6 months</time_frame>
    <description>Development of any MACE (A combination of any major cardiovascular events, including death, heart failure, post-infarction angina or new myocardial infarction) during a 6 months follow up after angioplasty and stent placement</description>
  </secondary_outcome>
  <enrollment type="Actual">45</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Coronary Syndrome, Acute</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      total blood blood serum, and blood plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  Ischemic patients who are submitted to a percutaneous coronary intervention.

          -  Atherosclerotic patients with coronary stent.

          -  All the patients included are from the hospital &quot;20 de noviembre, ISSSTE&quot; in Mexico
             City.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Coronary syndrome patients

          -  Patients with Endothelial dysfunction

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan A. Suárez-Cuenca, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Medical Center &quot;20 de Noviembre&quot;, ISSSTE</name>
      <address>
        <city>Mexico City</city>
        <zip>03100</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado</investigator_affiliation>
    <investigator_full_name>Juan Antonio Suárez Cuenca</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>MACE</keyword>
  <keyword>EPCs</keyword>
  <keyword>Cardiovascular risk</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

